Literature DB >> 33402950

Prevalence and antibiotic susceptibility pattern of bacteriuria among HIV-seropositive patients attending the Bamenda Regional Hospital, Cameroon.

Moses Samje1, Onesimus Yongwa2, Alice Mbi Enekegbe2, Simon Njoya3.   

Abstract

BACKGROUND: HIV causes a decrease in CD4+ lymphocyte cells count, exposing the individual to infections (urinary tract infections). This study was carried out to determine the prevalence of bacteriuria and antimicrobial susceptibility pattern of bacteria isolates among HIV patients.
METHODS: Clean catch mid-stream urine samples were collected from 135 HIV- seropositive patients, cultured on Cystein lactose electrolyte deficient (CLED) agar and incubated at 370C for 24 hours. The modified Kirby-Bauer's disc diffusion method was used to assess susceptibility to antimicrobial agents.
RESULTS: The prevalence of bacteriuria was 67.4% (91/135). Staphylococcus aureus was the most predominant (42.9%) isolate, followed by Escherichia. coli (24.2%), then Coagulase negative Staphylococci (10.9%). The highest proportion of bacteria was isolated from patients having a CD4+ T-cell count of less than 300 cells/mm3 (39.6%). There was an association between the level of CD4+cell count and bacterial urinary tract infection (P= 0.001). Most sensitive drugs were gentamycin, vancomycin and amoxicillin-clavulanic acid while the drug with the greatest resistance was sulphamethoxazole-trimethoprim, with Enterococcus and Proteus showing 100% resistance to this drug.
CONCLUSION: Bacteriuria and resistance to commonly used antibiotics is prevalent among HIV/AIDS patients attending the Bamenda Regional Hospital. Therapy based on antimicrobial susceptibility test is encouraged.
© 2020 Samje M et al.

Entities:  

Keywords:  Bacteriuria; CD4+ T-cell; HIV-seropositive patients; susceptibility

Mesh:

Substances:

Year:  2020        PMID: 33402950      PMCID: PMC7751511          DOI: 10.4314/ahs.v20i3.7

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


Introduction

HIV remains a major global public health issue with the sub-Saharan Africa being the most affected with over 25.7 million people living with HIV/AIDS as of 20171. Infection with HIV progressively reduces the effectiveness of the immune system rendering the individual vulnerable to opportunistic infections and cancers1. Urinary tract infections (UTIs) have been reported to be among the most common infectious diseases for which patients seek medical treatment with an estimated incidence of 250 million annually2,3. Patients with low CD4+lymphocyte cell count are at risk of having some neurological symptoms which lead to urinary stasis and ultimately, infection. In addition, women, infants, the elderly, HIV/AIDS patients and those with underlying urological abnormalities are at increased risk of UTIs4. According to Njunda and others5, Gram negative bacteria including Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Enterobacter cloacae, and Serratia marcescens were responsible for most UTIs. The association between the incidence of bacteriuria and CD4+ T-cell counts has been conflicting. While some findings revealed a higher frequency of UTI among HIV-seropositive patients, others showed no correlation between the two infections5,6,15. The inevitable emergence and rise of antibiotic resistance in the management of urinary tract infections is a serious public health problem globally and especially in the developing countries. Common causes of resistance to antibiotics include their frequent use and misuse and the transmission of resistant bacteria strains from one individual to another7. The availability of just few antimicrobial agents leave clinicians with a limited number of antimicrobial agents to fight infection. This ultimately leads to drug pressure which can easily give rise to sub-optimal response or ineffectiveness to the commonly available antibiotics8. In order to effectively tackle this rising antibacterial resistance, WHO recommends the putting in place of surveillance system for the collection of information. This will entail that a country, amongst others get information on the trend in resistance, monitor the impact of intervention and inform treatment guidelines8. Akoachere and others9 reported that information on the pattern of resistance to community acquired uropathogens have not been extensively studied in Cameroon. Antimicrobial susceptibility testing (AST) is important in deciding the appropriate antimicrobial agent to be used for treatment. Unfortunately, the high cost of culture precludes the routine dependence on AST prior to prescription and treatment. In effect, the majority of treatment relies on the result of urinalysis and urine microscopy. The information gotten from these diagnostic methods is limited in guiding the clinician onhe ideal antimicrobial agent for a specific infection. This empiric practice could predispose the community to treatment failure and equally give rise to resistance. This study was therefore aimed at determining the etiologic agents of bacteriuria among HIV- seropositive patients and their antimicrobial susceptibility pattern to commonly used antibiotics as well as assessing the relationship between CD4+ T-cell counts and bacteriuria in these patients attending the Bamenda Regional Hospital.

Materials and methods

Study design

This was a cross-sectional hospital-based study carried out at the HIV/AIDS treatment center of the Bamenda Regional Hospital in the North West Region of Cameroon. People living with HIV/AIDS (PLWHIV/AIDS) attending the Treatment Center were recruited for this study. We excluded those who were already on antibiotic therapy. Information on socio-demographic characteristics, treatment status and the presence of signs and symptoms of urinary tract infection was obtained from the patient's record and interview.

Laboratory analyses

About forty milliliters of clean catch mid-stream urine specimen was collected from each participant using a sterile wide mouth container, avoiding all contaminations. The samples were brought to laboratory within 30 minutes of collection for microscopy, culture and subsequent antibiotic susceptibility testing. CD4+T-cell counts was done using blood samples collected from all those who gave urine samples and analysed using Alere PimaTM(Alere Technologies GmbH, Germany). In the laboratory, samples were inoculated unto Cystein lactose electrolyte deficient (CLED) agar plates using a 0.01 ml loop, and incubated at 37°C for 24 hours. Following current guidelines which indicates that for a single isolate a density of 105 CFU/ml indicates infection after 24 hours coupled with the number of distinct colonies ranging from 30–300, the bacterial species was identified and antibiotic susceptibility done10. Examination of culture plates were done after 24 hours of incubation. Following significant detection of growth, the bacteria species were first identified morphologically/span> by their presentation on CLED agar, followed by Gram stain and biochemical testing (coagulase, catalase, oxidase). The modified Kirby Bauer disc diffusion method was used to do antimicrobial sensitivity test on the different bacteria isolated11,12. The following antibiotics (commonly prescribed in our setting for UTI) were used on the isolates were Ceftriaxone (5µg), Amoxicillin-clavulanic acid (30µg), Ciprofloxacin (5 µg), Gentamycin (10 µg), Vancomycin (5 µg), Sulphamethoxazole-Trimethoprim (10 µg) and Streptomycin (10 µg). The diameters were compared with an interpretative chart and interpreted as sensitive/susceptible, intermediate or resistant. Multidrug resistant bacteria was defined as resistance to three or more antimicrobial classes13.

Statistical analysis

Data was analyzed using IBM SPSS Statistics version 21. Differences in the prevalence of the various bacteria isolated were examined using the Chi-square(χ2) test. Difference between variables with p-value less than or equal to 0.05 was considered statistically significant.

Results

Overall, a total of 135 samples from people living with HIV/AIDS(PLWHIV/AIDS) was analyzed and of these, females (64.4%) and those of the age group 41–50 years (39.3%) constituted the majority, the mean age of study participants was 45.79±9.255 standard deviation. Most of the 135 participants (68.9%) were asymptomatic for urinary tract infections and the majority (40%) had CD4+ T-cell counts of less than 300 cells/mm3, the mean CD4 count was 409.24±196.646 standard deviation. A total of 131 (97%) of these 135 subjects were on antiretroviral therapy while 4 were ART naïve.

Prevalence of bacteriuria

The overall prevalence of bacteriuria among the 135 PLWHIV/AIDS was 67.4% (91/135). Among these, the majority with positive bacterial culture were female (86.2%) and those of the age group greater than 50 years. A significant difference (p=0.001) was observed in the prevalence among gender and age group. In like manner, a significant difference in positive culture was also noticed among CD4+ T-cell counts. The least infected were those with tertiary level of education, singles and those who had symptoms of UTIs (Table 1).
Table 1

The Prevalence of bacteriuria among 135 HIV- seropositive patients attending the HIV/AIDS Treatment Centre of the Bamenda Regional Hospital

VariablesNumber (%)Positive BacteriaNegative BacteriaP-value
culture (%)culture (%)
Sex
Male48(35.6)16(33.3)32(66.7)0.001
Female87(64.4)75(86.2)12(13.8)
Age Range(years)
20–307(5.2)3(42.6)4(57.1)
31–4030(22.2)12(40)18(60)0.001
41–5053(39.3)41(77.4)12(22.6)
50+45(33.3)35(77.8)10(22.2)
Educational Level
Primary88(65.2)63(71.6)25(28.4)
Secondary30(22.2)18(60)12(40)0.096
Tertiary17(12.6)10(58.8)7(41.2)
Marital Status
Single28(20.7)14(50)14(50)
Married102(75.6)74(72.5)28(27.5)0.073
Widow/Widower5(3.7)3(60)2(40)
Symptoms of UTI
Present42(31.1)24(57.1)18(42.9)0.66
Absent93(68.9)67(72.0)26(28.0)
CD4 cells/mm3
<30054(40)37(68.5)17(31.5)
300–50050(37)33(66)17(34)0.001 (Odd
>50031(23)21(67.7)10(32.3)Ratio 1.078)
Treatment
On ART131(97)90(68.7)41(31.3)0.44
ART naïve4(3)2(50)2(50)
The Prevalence of bacteriuria among 135 HIV- seropositive patients attending the HIV/AIDS Treatment Centre of the Bamenda Regional Hospital

Species of bacteria isolated

The bacteria species isolated were Staphylococcus aureus, Escherichia. coli, Coagulase negative Staphylococci (CONS), Klebsiella spp, Enterococci spp and Proteus spp. Of these species, Staphylococcus aureus was the most predominant (42.9%), followed by Escherichia coli (24.2%), then Coagulase negative Staphylococci (CONS) (10.9%). Overall, Klebsiella spp was 8.8%, while Enterococci spp and Proteus spp were both 6.6%. The highest number of significant bacteria growths for the six isolated species was observed in female, aged 41–50, married and who have attained only primary level of education (Table 2). Except for S. aureus, those with CD4+ T-cell counts less than 300 recorded the highest number of the isolated bacteria (Figure 1).
Table 2

Distribution of isolated bacteria by socio-demographic characteristics

VariableIsolated Bacteria
S. aureusCONSE. coliEnterococci sppKlebsiella sppProteus spp
GenderMale806200
Female311016486
Age Range20–30200001
31–40602040
41–502084423
50+11216222
Marital StatusSingle622040
Married32820644
Widow/Widower100002
Level of EducationPrimary31416264
Secondary644220
Tertiary222202
UTI SymptomsSymptomatic1624020
Asymptomatic23818666
HIV statusHIV+391022686
HIV naïve410010
Treatment ART371022686
Naïve200000
Figure 1

Association between CD4 count and bacteriuria

Distribution of isolated bacteria by socio-demographic characteristics Association between CD4 count and bacteriuria

Antibiotic susceptibility Pattern

S. aureus was most sensitive to gentamycin and vancomycin with a sensitivity of 84.6% and 79.5% respectively. CONS showed the highest sensitivity of 80% to gentamycin and ceftriaxone while E. coli was most sensitive to gentamycin, ceftriaxone and amoxicillin-clavulanic acid (63.6%). Proteus spp showed highest sensitivity to vancomycin (83.3%). As shown in table 3, sulphamethoxazole-trimethoprim recorded the greatest resistance. This drug showed a 100% resistance to both Enterococcus spp and Proteus spp and 80% to CONS.
Table 3

Antibiotic Susceptibility pattern of isolated bacteria

Isolated BacteriaSensitivity PatternCRO (5µg)AMC (30µg)CPR (5 µg)GN (10 µg)VA (5 µg)SXT (10 µg)S (10 µg)
S. aureusS2725253331727
I88124462
R462242610
E. coliS1414101412212
I6084444
R28446166
CONSS8268602
I2820024
R0022484
Klebsiella sppS2626608
I2042220
R4220060
Enterococcus sppS4424404
I2222202
R0020060
Proteus sppS1200503
I2012003
R3454160

CRO-Ceftriaxone, AMC-Amoxicillin-clavulanic acid, CPR-Ciprofloxacin, GN-Gentamycin, VA-Vancomycin, SXT-Sulphamethoxazole-Trimethoprim, S-Streptomycin.

S- Sensitive, I-Intermediate, R-Resistant.

Antibiotic Susceptibility pattern of isolated bacteria CRO-Ceftriaxone, AMC-Amoxicillin-clavulanic acid, CPR-Ciprofloxacin, GN-Gentamycin, VA-Vancomycin, SXT-Sulphamethoxazole-Trimethoprim, S-Streptomycin. S- Sensitive, I-Intermediate, R-Resistant.

Discussion

The prevalence of bacteriuria among people living with HIV/AIDS, attending the HIV/AIDS Treatment Centre was 67.4% with S. aureus being the most encountered bacteria species. Subjects with CD4+ T-cell counts less than 300 cells/mm3 were more frequently infected and sulphamethoxazole-trimethoprim recorded the greatest resistance to all the isolated bacteria. Our current findings in this study shows that the prevalence of bacteriuria among HIV-sero patients at the Regional Hospital, Bamenda is higher than those of other studies carried out in Bamenda and Buea5,9. The previous studies in Bamenda by Njunda et al focussed solely on coliforms. This could explain the lower prevalence they recorded in their studies almost ten years ago. In a similar study also conducted in both Bamenda and Buea by Akoachere et al., the study participants were not limited to HIV- seropositive patients. Our study has generated data for HIV- seropositive patients in this part of the country where information on bacteriuria among HIV- seropositive patients is scarce. When our findings was compared to those of other countries, the prevalence we recorded is higher than those observed in different parts of Nigeria (10.9% and 57.3), Ethiopia (9.2% and 11.3%), South Africa (37.6%)and India3,4,10,14–16. Our observation on female being more infected is consistent with almost all the studies we have come across5,6,24. This could be explained in part by the relatively short urethra in female whose proximity to the anus predisposes them to infection addition to likely poor behavioural practices. Unlike most of the studies we came across, those of the age group 41–50 years were more infected in our study. Concerning the level of education and bacteria isolated in this study, we observed that those who had attended only primary level of education were most infected and those who attended secondary schools might have received basic education on hygiene and risky behaviour thus creating awareness and consequently reducing the risk of infection. This is also in line with our findigs which revealed that those who had attended only primary level of education were the most infected. Contrary to the findings of others in Nigeria and Ethiopia, bacteriuria in asymptomatic patients was higher in our study than their symptomatic counterpart15,17. In this study, S. aureus was found to be the most prevalent bacteria species isolated. This is contrary to the findings of Akoachere et al and Njunda et al in both Bamenda and Buea who showed that E. coli was the most frequently encountered bacteria5,9. Our findings however, correlated with those of Murugesh et al in India and Omoregie et al in Nigeria who reported S. aureus to be the most frequently encountered bacteria6,15,18. Like our study, the latter studies had HIV-seropositive patients as their study participants. Colonization with S. aureus has been reported to be a risk factor for subsequent clinical infection in HIV/AIDS patients and the bacteria is an important cause of morbidity and mortality. With respect to CD4+ T-cell counts, patients with less than 300cells/mm3 where more predisposed to UTIs than those who had counts greater than 500cells/mm3. This correlates with other studies carried out earlier in the same hospital5, and other studies in Tchad19, Ethiopia15, Bangalore and the Netherlands14,20. No relationship, has however, been shown to exist between bacteriuria and CD4+ T-cell counts among HIV-seropositive patients by several other studies carried out in different countries6,21–22. A drop in the number of CD4+ T-cells predisposes the immune compromised individual to various opportunistic infections amongst which are UTIs. Accompanying neutropenia to antiretroviral therapy alongside physical and psychological stress could account for this observation. We noticed that patients with CD4+ T-cell counts greater than 500/mm3 were often asymptomatic. This supports the hypothesis that a low CD4+ T- cell count is associated to symptomatic bacteriuria among HIV- seropositive patients in this community. For all the bacteria species isolated in this study, the drug with the greatest resistance pattern was sulphamethoxazole-trimethoprim, a drug commonly used to treat infections such as urinary tract infections, middle ear infections, bronchitis, traveler's diarrhea, and shigellosis. In previous studies carried out in Bamenda, this drug has been reported to show the lowest susceptibility to all the isolated bacteria5,9. Majority of HIV/AIDS patients are placed on this drug when they have cough and it is also a prophylactic treatment against Pneumocystis carinii. The drug is used frequently in the community for auto-medication of common ailments especially stomach disorders and cough. The dose and regimen used in auto-medication is questionable and could expose this community to the acquisition of resistance. The most sensitive drugs; gentamycin, vancomycin and amoxicillin-clavulanic, has also been reported in other studies9,23. We also observed that most of the bacteria strains isolated were resistant to two or more antibiotics. This agrees with reports on the emergence of multidrug resistant bacteria strains in the management of UTI among HIV individuals. Antimicrobial resistance is a serious public health problem particularly in developing countries where, lamentably, poverty and ignorance lead to the purchase and use of sub-standard drugs of questionable origin and quality which are in circulation. More so, prescription of antimicrobial agents not based on susceptibility test could facilitate the development of resistance to these commonly and frequently used antibiotics. The upsurge in antibiotic resistance noticed in this study corroborates with earlier work5,15,24 where antibiotic abuse and high prevalence of self-medication with antibiotics were identified as being responsible for resistance. The occurrence of multiple drug resistant bacteria in the urine of HIV-seropositive individuals could also significantly increase the risk of opportunistic infections which is less susceptible to antibiotic treatments. One limitation recognized in this study was the low sample size which can restrain the generalization of our observation. This however, was because we focussed only on HIV patients and not the entire community. The sample size is also a reflection of the study population.

Conclusion

Our findings showed that more than half of HIV-seropositive patients have bacteriuria with Staphylococcus aureus, Escherichia coli and Coagulase Negative Staphylococci being the most encountered species. Sulphamethoxazole-trimethoprim recorded the greatest resistance pattern to all the isolates tested while Proteus spp and Enterococcus spp demonstrated the highest multidrug resistance. The indiscriminate use of antibiotics should be discouraged and mechanism for the monitoring of antimicrobial resistance be put in place.
  9 in total

1.  Asymptomatic bacteriuria in human immunodeficiency (HIV)-infected women.

Authors: 
Journal:  Prim Care Update Ob Gyns       Date:  1998-07-01

2.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

3.  Urinary tract infection in adults: research priorities and strategies.

Authors:  A R Ronald; L E Nicolle; E Stamm; J Krieger; J Warren; A Schaeffer; K G Naber; T M Hooton; J Johnson; S Chambers; V Andriole
Journal:  Int J Antimicrob Agents       Date:  2001-04       Impact factor: 5.283

4.  Bacteriuria in a cohort of predominantly HIV-1 seropositive female commercial sex workers in Nairobi, Kenya.

Authors:  J Ojoo; J Paul; B Batchelor; M Amir; J Kimari; C Mwachari; J Bwayo; F Plummer; G Gachihi; P Waiyaki; C Gilks
Journal:  J Infect       Date:  1996-07       Impact factor: 6.072

5.  Urinary tract infection among asymptomatic HIV patients in Benin City, Nigeria.

Authors:  R Omoregie; N O Eghafona
Journal:  Br J Biomed Sci       Date:  2009       Impact factor: 3.829

6.  Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count).

Authors:  A I Hoepelman; M van Buren; J van den Broek; J C Borleffs
Journal:  AIDS       Date:  1992-02       Impact factor: 4.177

7.  Bacterial uropathogens in urinary tract infection and antibiotic susceptibility pattern in jimma university specialized hospital, southwest ethiopia.

Authors:  Getenet Beyene; Wondewosen Tsegaye
Journal:  Ethiop J Health Sci       Date:  2011-07

8.  Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.

Authors:  Mohammed Akram; Mohammed Shahid; Asad U Khan
Journal:  Ann Clin Microbiol Antimicrob       Date:  2007-03-23       Impact factor: 3.944

9.  Etiologic profile and antimicrobial susceptibility of community-acquired urinary tract infection in two Cameroonian towns.

Authors:  Jane-Francis Tatah Kihla Akoachere; Suylika Yvonne; Njom Henry Akum; Esemu Nkie Seraphine
Journal:  BMC Res Notes       Date:  2012-05-07
  9 in total
  1 in total

1.  Magnitude and associated factors of urinary tract infections among adults living with HIV in Ethiopia. Systematic review and meta-analysis.

Authors:  Molla Yigzaw Birhanu; Samuel Derbie Habtegiorgis; Wodaje Gietaneh; Simegn Alemu; Tesfa Birlew Tsegaye; Getamesay Molla Bekele; Abtie Abebaw; Tebelay Dilnessa; Haymanot Tewabe Elmneh; Haile Amha; Daniel Bekele Ketema; Tsige Gebre Anto; Melaku Desta; Selamawit Shita Jemberie
Journal:  PLoS One       Date:  2022-04-01       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.